Form 4 for SMMT Summit Therapeutics Inc.
Accepted 2025-04-09 00:00:00 ET · period of report 2025-04-08 · accession 0001599298-25-000058 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-09 | 2025-04-08 | SMMT | DUGGAN ROBERT W | Co-CEO, Dir, 10% | X - OptEx | $1.58 | +3.99M | 555.68M | +0.7% | +$6.30M |
| D | 2025-04-09 | 2025-04-08 | SMMT | DUGGAN ROBERT W | Co-CEO, Dir, 10% | X - OptEx | $0.00 | +3.99M | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-08 | X | A | 3,985,055 | $1.58 | 555,680,151 | D | — | — | |
| 2 | Derivative | Warrant (right to buy) | 2025-04-08 | X | A | 3,985,055 | $0.00 | 0 | D | $1.58 · 2020-06-24 to 2029-12-24 | 3,985,055 Common Stock |